Annual Accounts Payable
$2.12 M
-$6.86 M-76.43%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual accounts payable is $2.12 million, with the most recent change of -$6.86 million (-76.43%) on December 31, 2023.
- During the last 3 years, EIGR annual accounts payable has fallen by -$2.52 million (-54.42%).
- EIGR annual accounts payable is now -76.43% below its all-time high of $8.97 million, reached on December 31, 2022.
Performance
EIGR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.12 M
-$2.74 M-56.46%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly accounts payable is $2.12 million, with the most recent change of -$2.74 million (-56.46%) on December 31, 2023.
- Over the past year, EIGR quarterly accounts payable has dropped by -$6.86 million (-76.43%).
- EIGR quarterly accounts payable is now -82.16% below its all-time high of $11.86 million, reached on March 31, 2023.
Performance
EIGR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EIGR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.4% | -76.4% |
| 3 y3 years | -54.4% | -54.4% |
| 5 y5 years | -63.7% | -63.7% |
EIGR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.4% | at low | -82.2% | at low |
| 5 y | 5-year | -76.4% | at low | -82.2% | at low |
| alltime | all time | -76.4% | +341.5% | -82.2% | +827.6% |
Eiger BioPharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.12 M(-76.4%) | $2.12 M(-56.5%) |
| Sep 2023 | - | $4.86 M(-1.8%) |
| Jun 2023 | - | $4.95 M(-58.3%) |
| Mar 2023 | - | $11.86 M(+32.1%) |
| Dec 2022 | $8.97 M(+15.6%) | $8.97 M(-14.5%) |
| Sep 2022 | - | $10.50 M(+5.6%) |
| Jun 2022 | - | $9.95 M(+7.9%) |
| Mar 2022 | - | $9.22 M(+18.7%) |
| Dec 2021 | $7.76 M(+67.3%) | $7.76 M(+15.0%) |
| Sep 2021 | - | $6.75 M(+52.0%) |
| Jun 2021 | - | $4.44 M(-42.6%) |
| Mar 2021 | - | $7.75 M(+67.0%) |
| Dec 2020 | $4.64 M(-27.7%) | $4.64 M(-43.8%) |
| Sep 2020 | - | $8.25 M(+59.3%) |
| Jun 2020 | - | $5.18 M(-41.6%) |
| Mar 2020 | - | $8.87 M(+38.3%) |
| Dec 2019 | $6.41 M(+10.0%) | $6.41 M(-29.2%) |
| Sep 2019 | - | $9.06 M(+25.9%) |
| Jun 2019 | - | $7.19 M(+30.3%) |
| Mar 2019 | - | $5.52 M(-5.3%) |
| Dec 2018 | $5.83 M | $5.83 M(-10.5%) |
| Sep 2018 | - | $6.52 M(+46.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $4.44 M(+46.7%) |
| Mar 2018 | - | $3.02 M(-5.0%) |
| Dec 2017 | $3.18 M(+20.6%) | $3.18 M(-23.6%) |
| Sep 2017 | - | $4.17 M(-6.7%) |
| Jun 2017 | - | $4.47 M(+40.2%) |
| Mar 2017 | - | $3.19 M(+20.8%) |
| Dec 2016 | $2.64 M(+450.9%) | $2.64 M(-35.2%) |
| Sep 2016 | - | $4.08 M(+225.0%) |
| Jun 2016 | - | $1.25 M(-79.3%) |
| Mar 2016 | - | $6.06 M(+1165.6%) |
| Dec 2015 | $479.00 K(-92.7%) | $479.00 K(+110.1%) |
| Sep 2015 | - | $228.00 K(-91.7%) |
| Jun 2015 | - | $2.76 M(-1.0%) |
| Mar 2015 | - | $2.79 M(-57.3%) |
| Dec 2014 | $6.53 M(+367.7%) | $6.53 M(+197.3%) |
| Sep 2014 | - | $2.20 M(+102.0%) |
| Jun 2014 | - | $1.09 M(+48.8%) |
| Mar 2014 | - | $731.00 K(-47.7%) |
| Dec 2013 | $1.40 M(+145.5%) | $1.40 M(+39.0%) |
| Sep 2013 | - | $1.00 M(+43.8%) |
| Jun 2013 | - | $699.00 K |
| Dec 2012 | $569.00 K(+2.9%) | - |
| Dec 2011 | $553.00 K | - |
FAQ
- What is Eiger BioPharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual accounts payable year-on-year change?
- What is Eiger BioPharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly accounts payable year-on-year change?
What is Eiger BioPharmaceuticals annual accounts payable?
The current annual accounts payable of EIGR is $2.12 M
What is the all time high annual accounts payable for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual accounts payable is $8.97 M
What is Eiger BioPharmaceuticals annual accounts payable year-on-year change?
Over the past year, EIGR annual accounts payable has changed by -$6.86 M (-76.43%)
What is Eiger BioPharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of EIGR is $2.12 M
What is the all time high quarterly accounts payable for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly accounts payable is $11.86 M
What is Eiger BioPharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, EIGR quarterly accounts payable has changed by -$6.86 M (-76.43%)